| 摘要 |
There is disclosed pharmaceutical compositions and methods useful in obviating or mitigating tolerance during organic nitrate therapy. The compositions and methods comprise compounds selected from the group comprising a folate compound, a folate derivative compound, a hydrobiopterin compound, a hydrobiopterin derivative compound and mixtures thereof.
|
